中东和非洲胰岛素市场预测至 2028 年 - COVID-19 影响和区域分析 - 按类型（长效胰岛素、速效胰岛素、短效胰岛素和传统人胰岛素、浓缩胰岛素和复方胰岛素、生物仿制药胰岛素、胰高血糖素样肽-1 (GLP-1)、笔和针等）
No. of Pages: 181 | Report Code: BMIRE00027244 | Category: Life Sciences
No. of Pages: 181 | Report Code: BMIRE00027244 | Category: Life Sciences
主要参与者在中东和非洲的主导地位非洲导致胰岛素市场价值增加。诺和诺德公司、艾丽莉莉公司、赛诺菲公司累计市场收入超过90%。这主要归功于这些主导企业目前持有的专利的常青化。此外，患者对生物仿制药缺乏信任是促进胰岛素市场增长的一个重要因素。根据健康行动国际 (2019) 进行的一项研究，礼来公司、诺和诺德和赛诺菲是仅有的三个胰岛素制造商，它们创造了市场约 90% 的收入。
< p>中东和非洲的胰岛素市场非洲分为沙特阿拉伯、阿联酋、南非和中东和非洲其他地区。由于糖尿病患病率上升、医疗保健支出激增、人们对糖尿病的认识不断提高以及为控制糖尿病发病率而采取的预防措施，预计该地区将为市场参与者提供显着的增长机会。在沙特阿拉伯，糖尿病影响约 20% 的人口。该疾病占该国医疗保健总支出的四分之一。糖尿病是该国最流行的糖尿病形式。根据国际糖尿病联合会的数据，2019 年沙特阿拉伯约有 700 万人患有糖尿病。该国糖尿病患病率排名第八，其中包括患有 1 型糖尿病的儿童和成人。就发病率而言，中国位居世界第四位国家，每 100 万人中约有 33.5 人患有 1 型糖尿病。
MEA 胰岛素市场按类型和国家/地区进行细分。根据类型，市场分为长效胰岛素、速效胰岛素、短效胰岛素和短效胰岛素。传统人胰岛素、浓缩胰岛素和胰岛素组合胰岛素、生物仿制药胰岛素、胰高血糖素样肽-1 (GLP-1)、pen &针等。长效胰岛素细分市场在 2022 年占据最大的市场份额。
Biocon;礼来公司； 葛兰素史克 plc。；默克公司有限公司； Novo Nordisk A/S；辉瑞公司； 赛诺菲; 通化东宝药业有限公司；和 Wockhardt 是该地区胰岛素市场的领先公司。
Strategic insights for Middle East & Africa Insulin involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 3,255.91 Million |
| Market Size by 2028 | US$ 5,549.57 Million |
| Global CAGR (2022 - 2028) | 9.2% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 中东和非洲
|
| Market leaders and key company profiles |
The regional scope of Middle East & Africa Insulin refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Middle East & Africa Insulin Market is valued at US$ 3,255.91 Million in 2022, it is projected to reach US$ 5,549.57 Million by 2028.
As per our report Middle East & Africa Insulin Market, the market size is valued at US$ 3,255.91 Million in 2022, projecting it to reach US$ 5,549.57 Million by 2028. This translates to a CAGR of approximately 9.2% during the forecast period.
The Middle East & Africa Insulin Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Insulin Market report:
The Middle East & Africa Insulin Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East & Africa Insulin Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East & Africa Insulin Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East & Africa Insulin Market
